GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Cyclically Adjusted PB Ratio

St Pharm Co (XKRX:237690) Cyclically Adjusted PB Ratio : 3.99 (As of Jun. 01, 2025)


View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Cyclically Adjusted PB Ratio?

As of today (2025-06-01), St Pharm Co's current share price is ₩79200.00. St Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩19,864.60. St Pharm Co's Cyclically Adjusted PB Ratio for today is 3.99.

The historical rank and industry rank for St Pharm Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:237690' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.66   Med: 3.96   Max: 4.85
Current: 3.99

During the past years, St Pharm Co's highest Cyclically Adjusted PB Ratio was 4.85. The lowest was 3.66. And the median was 3.96.

XKRX:237690's Cyclically Adjusted PB Ratio is ranked worse than
75.79% of 694 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs XKRX:237690: 3.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

St Pharm Co's adjusted book value per share data for the three months ended in Mar. 2025 was ₩24,547.543. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩19,864.60 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


St Pharm Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for St Pharm Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Cyclically Adjusted PB Ratio Chart

St Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.64

St Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 4.64 3.63

Competitive Comparison of St Pharm Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


St Pharm Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where St Pharm Co's Cyclically Adjusted PB Ratio falls into.


;
;

St Pharm Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

St Pharm Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=79200.00/19864.60
=3.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

St Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, St Pharm Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24547.543/122.5900*122.5900
=24,547.543

Current CPI (Mar. 2025) = 122.5900.

St Pharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.051 0.000
201509 0.000 100.111 0.000
201512 5,998.388 100.220 7,337.253
201603 0.000 100.561 0.000
201606 15,459.156 100.791 18,802.706
201609 16,335.564 101.461 19,737.366
201612 16,946.801 101.561 20,455.708
201703 17,152.610 102.851 20,444.591
201706 17,915.473 102.611 21,403.664
201709 18,342.963 103.491 21,728.215
201712 18,818.760 102.991 22,399.979
201803 18,364.323 104.101 21,625.985
201806 18,629.703 104.130 21,932.284
201809 18,271.684 105.651 21,201.279
201812 17,772.779 104.351 20,879.256
201903 16,992.837 104.491 19,936.204
201906 16,832.886 104.881 19,675.112
201909 16,810.139 105.200 19,588.869
201912 16,124.694 105.121 18,804.241
202003 15,949.518 105.354 18,558.837
202006 16,104.796 105.112 18,782.734
202009 15,737.236 106.198 18,166.397
202012 15,830.194 105.765 18,348.377
202103 15,544.380 107.357 17,749.956
202106 15,876.386 107.579 18,091.760
202109 16,329.904 108.759 18,406.562
202112 17,171.255 109.676 19,193.046
202203 16,743.538 111.848 18,351.605
202206 17,028.496 114.072 18,300.002
202209 17,706.206 114.715 18,921.659
202212 17,950.547 115.179 19,105.512
202303 17,751.258 116.507 18,678.013
202306 17,947.647 117.182 18,775.923
202309 20,014.894 118.964 20,625.013
202312 20,445.019 118.837 21,090.677
202403 20,600.091 120.123 21,023.126
202406 21,934.272 120.007 22,406.324
202409 24,301.303 120.861 24,648.909
202412 24,965.632 121.135 25,265.462
202503 24,547.543 122.590 24,547.543

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


St Pharm Co  (XKRX:237690) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


St Pharm Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of St Pharm Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


St Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines